Treatment goals in familial hypercholesterolaemia-time to consider low-density lipoprotein-cholesterol burden
Eur J Prev Cardiol
.
2022 Dec 7;29(17):2278-2280.
doi: 10.1093/eurjpc/zwab228.
Authors
Gisle Langslet
1
,
Kirsten B Holven
2
3
,
Martin P Bogsrud
4
Affiliations
1
Lipid Clinic, Oslo University Hospital, Aker Sykehus, P.O. Box 4959 Nydalen, 0424 Oslo, Norway.
2
Norwegian National Advisory Unit on Familial Hypercholesterolemia, Oslo University Hospital, P.O. Box 4959 Nydalen, 0424 Oslo, Norway.
3
Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1046 Blindern, 0317 Oslo, Norway.
4
Unit for Cardiac and Cardiovascular Genetics, Oslo University Hospital, P.O. Box 4959 Nydalen, 0424 Oslo, Norway.
PMID:
34935933
DOI:
10.1093/eurjpc/zwab228
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Cholesterol, LDL
Humans
Hyperlipoproteinemia Type II* / diagnosis
Hyperlipoproteinemia Type II* / drug therapy
Hyperlipoproteinemia Type II* / genetics
Substances
Cholesterol, LDL